Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
A. M. M. Hasan, P. Cremaschi, D. Wetterskog, A. Jayaram, S. Q. Wong, S. Williams, A. Pasam, A. Trigos, B. Trujillo, E. Grist, S. Friedrich, O. Vainauskas, M. Parry, M. Ismail, W. Devlies, , G. Attard
The paper identifies treatment-selected lethal prostate cancer clones through copy number analysis of metastases from multiple organs.
bioRxiv · Sep 1, 2022 · PreprintCancer Biology